HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Notch1 signaling impairs regulatory T cells during multisystem inflammatory syndrome in children.

Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a rare pediatric inflammatory disorder characterized by immune cell hyperactivation, cytokine storm, and the production of autoantibodies. The mechanisms underlying such immune dysregulation still need to be unraveled. In this issue of the JCI, Benamar et al. demonstrated the critical role of the Notch receptor 1/CD22 (Notch1/CD22) axis in Tregs, which, when activated, impairs Treg functions and promotes inflammation. They showed that the Notch1/CD22 axis contributed to dysregulated immune responses in MIS-C. These findings may have implications for MIS-C and many other inflammatory diseases.
AuthorsMagali Noval Rivas, Moshe Arditi
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 133 Issue 1 (01 03 2023) ISSN: 1558-8238 [Electronic] United States
PMID36594470 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Comment)
Chemical References
  • Receptor, Notch1
  • NOTCH1 protein, human
Topics
  • Humans
  • Child
  • T-Lymphocytes, Regulatory
  • Receptor, Notch1 (genetics)
  • Systemic Inflammatory Response Syndrome
  • COVID-19

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: